Skip to main content
. Author manuscript; available in PMC: 2009 Aug 7.
Published in final edited form as: J Control Release. 2008 May 1;129(3):179–186. doi: 10.1016/j.jconrel.2008.04.021

Table 1.

Surface Plasmon Resonance Data for Antagonist Binding to Immobilized TNFα

Antagonist kon (104 M−1 s−1) koff (10−4 s−1) KD (nM) KD/KD,sTNFRII
sTNFRII 4.5 ± 0.5 0.22 ± 0.08 0.47 ± 0.12 1
ELP-sTNFRII (ITC purified) 1.4 ± 0.6 10 ± 6* 73 ± 12* 153
ELP-sTNFRII (Unfolded) 0.12 ± 0.08 5 ± 2* 470 ± 180* 989
ELP-sTNFRII (refold mixture) 0.7 ± 0.4 1.1 ± 0.4* 17 ± 8* 35
ELP-sTNFRII (immunoprecipitated) 4.4 ± 1.8 1.6 ± 0.7* 3.5 ± 0.3* 7
ELP-sTNFRII (TNFα-affinity purified) 4.6 ± 1.8 0.9 ± 0.2* 2.1 ± 0.9* 4.5
ELP 0.013 ± 0.018# 42 ± 39 7400 ± 400# 150000

kon – association rate constant

koff – dissociation rate constant

KD – equilibrium dissociation constant

*

values for ELP-sTNFRII are significantly different from values for sTNFRII at p < 0.05

#

values for ELP are significantly different from values for both sTNFRII and ELP-sTNFRII at p < 0.05

HHS Vulnerability Disclosure